QA: Mirati Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2019_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 226,660,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 473,000
3 remainder_Assets 1,321,000
4 LiabilitiesCurrent 26,146,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 732,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,073,909
9 ResearchAndDevelopmentExpense 97,693,366
10 remainder_Expenses 0
11 remainder_Revenues 12,926,000
12 remainder_NetIncome 5,457,620
13 remainder_ComprehensiveNetIncome -7,090
  yvar yval
0 Assets 228,454,000
1 Liabilities 26,878,000
2 Expenses 119,767,275
3 Revenues 12,926,000
4 StockholdersEquity 201,576,000
5 NetIncome -101,383,655
6 ComprehensiveNetIncome -101,387,200
7 BaseVar 196,744,992
8 EconomicCapitalRatiobeforeLimitedLiability 2.65
9 EconomicCapitalRatio 3.45

Edgar->Model Mapping

Feature Distribution

Change over Time